Mersana Therapeutics Inc’s recent filing unveils that its Director Protopapas Anna unloaded Company’s shares for reported $79671.0 on Jan 16 ’24. In the deal valued at $2.71 per share,29,399 shares were sold. As a result of this transaction, Protopapas Anna now holds 125,153 shares worth roughly $0.47 million.
Then, Lowinger Timothy B sold 10,409 shares, generating $28,208 in total proceeds. Upon selling the shares at $2.71, the SVP, Chief Sci.&Tech. Officer now owns 199,329 shares.
Before that, DeSchuytner Brian sold 9,327 shares. Mersana Therapeutics Inc shares valued at $25,276 were divested by the SVP, COO & CFO at a price of $2.71 per share. As a result of the transaction, DeSchuytner Brian now holds 54,511 shares, worth roughly $0.2 million.
JP Morgan upgraded its Mersana Therapeutics Inc [MRSN] rating to a Neutral from a an Underweight in a research note published recently. A number of analysts have revised their coverage, including Wedbush’s analysts, who increased its forecast for the stock in late February from “a Neutral” to “an Outperform”. Guggenheim also remained covering MRSN and has increased its forecast on February 29, 2024 with a “Buy” recommendation from previously “Neutral” rating. BTIG Research revised its rating on February 29, 2024. It rated MRSN as “a Buy” which previously was an “a Neutral”.
Price Performance Review of MRSN
On Tuesday, Mersana Therapeutics Inc [NASDAQ:MRSN] saw its stock fall -0.79% to $3.76. Over the last five days, the stock has lost -8.29%. Mersana Therapeutics Inc shares have risen nearly 62.07% since the year began. Nevertheless, the stocks have fallen -9.40% over the past one year. While a 52-week high of $9.62 was reached on 03/11/24, a 52-week low of $0.80 was recorded on 01/03/24. SMA at 50 days reached $4.48, while 200 days put it at $2.58. A total of 0.68 million shares were traded, compared to the trading of 1.23 million shares in the previous session.
Levels Of Support And Resistance For MRSN Stock
The 24-hour chart illustrates a support level at 3.71, which if violated will result in even more drops to 3.66. On the upside, there is a resistance level at 3.81. A further resistance level may holdings at 3.85. The Relative Strength Index (RSI) on the 14-day chart is 34.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.33, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.23%. Stochastics %K at 10.00% indicates the stock is a buying.
